Live from the NIH registry
Studies recruiting near Chula Vista right now
Top 25 of 1,275 recruiting studies, sorted by proximity — each links to its official registry page
ExoLuminate Study for Early Detection of Pancreatic Cancer
Pancreas Cancer, Exosomes
N/A
Observational 1,000 participants sought
Biological Dynamics — San Diego, California (10.6 mi)
· Sponsor: Biological Dynamics
Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative Infections
Gram-negative Bacterial Infections
Phase 2
Interventional 48 participants sought
Rady Children's Hospital — San Diego, California (10.6 mi)
· Sponsor: Pfizer
A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)
PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)
Phase 1
Interventional 9 participants sought
University of California, San Diego — La Jolla, California (21.4 mi)
· Sponsor: Rocket Pharmaceuticals Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Rady Children's Hospital - San Diego — San Diego, California (10.6 mi)
· Sponsor: National Cancer Institute (NCI)
ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Phase 1
Interventional 30 participants sought
University of California San Diego — San Diego, California (10.6 mi)
· Sponsor: Acepodia Biotech, Inc.
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Large B-cell Lymphoma
Phase 2
Interventional 250 participants sought
University of California, San Diego — San Diego, California (10.6 mi)
· Sponsor: Allogene Therapeutics
BladdEr Full OR Empty for Pelvic Radiation Therapy
Pelvic Neoplasm
Phase 3
Interventional 300 participants sought
University of California, San Diego — San Diego, California (10.6 mi)
· Sponsor: University of California, San Diego
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — San Diego, California (10.6 mi)
· Sponsor: Sameek Roychowdhury
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
University of California San Diego Moores Cancer Center — San Diego, California (10.6 mi)
· Sponsor: Relay Therapeutics, Inc.
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Chronic Obstructive Pulmonary Disease
Phase 3
Interventional 942 participants sought
Acclaim Clinical Research- Site Number : 8400068 — San Diego, California (10.6 mi)
· Sponsor: Sanofi
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Rady Children's Hospital - San Diego — San Diego, California (10.6 mi)
· Sponsor: Medtronic MiniMed, Inc.
ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1
Depressed Mood
N/A
Observational 5,000 participants sought
Salma Health — La Jolla, California (21.4 mi)
· Sponsor: Salma Health, Inc.
Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
Neuromyelitis Optica Spectrum Disorder
Phase 2
Interventional 15 participants sought
UCSD Altman Clinical and Translational Research Institute Building — La Jolla, California (21.4 mi)
· Sponsor: Amgen
Researchers At UC San Diego Are Learning About the Benefits of Human Milk and How It Influences Infant and Child Health
Breastfeeding, COVID-19 Infection
N/A
Observational 5,000 participants sought
University of California, San Diego — San Diego, California (10.6 mi)
· Sponsor: University of California, San Diego
Targeting Minority Stressors to Improve Eating Disorder Symptoms in Sexual Minority Individuals With Eating Disorders
Eating Disorders, Sexual Minorities
Phase 1
Interventional 30 participants sought
San Diego State University — San Diego, California (10.6 mi)
· Sponsor: Auburn University
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Solid Tumor, Adult, Metastatic Breast Cancer
Phase 1
Interventional 392 participants sought
University of California San Diego Moores Cancer Center — San Diego, California (10.6 mi)
· Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — La Jolla, California (21.4 mi)
· Sponsor: AstraZeneca
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Southern California Research Center — Coronado, California (10.6 mi)
· Sponsor: Janssen Research & Development, LLC
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
Prostate Cancer
Phase 4
Interventional 142 participants sought
University of California San Diego Health — San Diego, California (10.6 mi)
· Sponsor: Blue Earth Diagnostics
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Kaiser Permanente-San Diego Mission — San Diego, California (10.6 mi)
· Sponsor: SWOG Cancer Research Network
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
Parkinson Disease
N/A
Observational 4,500 participants sought
University of California San Diego — La Jolla, California (21.4 mi)
· Sponsor: Michael J. Fox Foundation for Parkinson's Research
Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma
Melanoma Stage III, Melanoma Stage IV
Phase 2
Interventional 25 participants sought
UC San Diego Moores Cancer Center — La Jolla, California (21.4 mi)
· Sponsor: University of California, San Francisco
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
Recurrent Glioblastoma, IDH-Wildtype, Recurrent MGMT-Methylated Glioblastoma
Phase 1, Phase 2
Interventional 97 participants sought
UC San Diego Moores Cancer Center — La Jolla, California (21.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Alzheimers Disease, Dementia
Phase 2, Phase 3
Interventional 280 participants sought
University of California San Diego Medical Center — La Jolla, California (21.4 mi)
· Sponsor: Washington University School of Medicine
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
Colitis, Ulcerative
N/A
Observational 300 participants sought
Scripps Clinic Torrey Pines — La Jolla, California (21.4 mi)
· Sponsor: Pfizer